US Equity
BCRX
— BIOCRYST PHARMACEUTICALS, INC.BioCryst Pharmaceuticals, Inc. is a biotechnology company that develops oral small molecule medicines for rare diseases, including hereditary angioedema.
💰 Market cap: $2.43B📍 4505 Emperor Blvd Ste 200, DURHAM, NC, 27703-8457 US🏷️ Biotechnology & Medical Research💵 Previous close: $9.34🔢 8,484 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $9.34 |
| 2026-07-23 | $9.38 |
| 2026-07-22 | $9.51 |
| 2026-07-21 | $9.42 |
| 2026-07-20 | $9.11 |
| 2026-07-17 | $9.29 |
| 2026-07-16 | $9.11 |
| 2026-07-15 | $9.41 |
| 2026-07-14 | $9.74 |
| 2026-07-13 | $9.91 |
| 2026-07-10 | $10.45 |
| 2026-07-09 | $10.72 |
| 2026-07-08 | $11.11 |
| 2026-07-07 | $10.99 |
| 2026-07-06 | $10.17 |
| 2026-07-02 | $9.84 |
| 2026-07-01 | $9.65 |
| 2026-06-30 | $10.00 |
| 2026-06-29 | $9.55 |
| 2026-06-26 | $9.94 |
| 2026-06-25 | $9.90 |
| 2026-06-24 | $10.00 |
| 2026-06-23 | $9.31 |
| 2026-06-22 | $9.14 |
| 2026-06-18 | $8.99 |
| 2026-06-17 | $8.95 |
| 2026-06-16 | $8.92 |
| 2026-06-15 | $9.06 |
| 2026-06-12 | $8.70 |
| 2026-06-11 | $8.50 |
| 2026-06-10 | $8.19 |
| 2026-06-09 | $8.33 |
| 2026-06-08 | $8.43 |
| 2026-06-05 | $8.41 |
| 2026-06-04 | $8.47 |
| 2026-06-03 | $8.25 |
| 2026-06-02 | $8.34 |
| 2026-06-01 | $8.57 |
| 2026-05-29 | $8.91 |
| 2026-05-28 | $9.10 |
| 2026-05-27 | $9.12 |
| 2026-05-26 | $8.47 |
| 2026-05-22 | $8.29 |
| 2026-05-21 | $8.37 |
| 2026-05-20 | $8.74 |
| 2026-05-19 | $8.77 |
| 2026-05-18 | $8.97 |
| 2026-05-15 | $9.02 |
| 2026-05-14 | $9.57 |
| 2026-05-13 | $9.60 |
| 2026-05-12 | $8.80 |
| 2026-05-11 | $8.58 |
| 2026-05-08 | $8.62 |
| 2026-05-07 | $8.90 |
| 2026-05-06 | $8.83 |
| 2026-05-05 | $9.03 |
| 2026-05-04 | $9.20 |
| 2026-05-01 | $9.19 |
| 2026-04-30 | $9.16 |
| 2026-04-29 | $8.99 |
| 2026-04-28 | $8.86 |